dengu
viru
denv
major
mosquitoborn
pathogen
infect
million
peopl
year
far
effect
treatment
vaccin
avail
recent
highli
crossreact
infectionenhanc
premembran
prm
specif
antibodi
found
domin
antidenv
immun
respons
human
rais
concern
vaccin
candid
contain
nativ
dengu
prm
sequenc
studi
isol
broadli
crossreact
prmspecif
antibodi
screen
nonimmun
human
fabphag
librari
four
serotyp
denv
antibodi
capabl
restor
infect
virtual
noninfecti
immatur
denv
imdenv
fccrbear
cell
remark
also
crossreact
cryptic
epitop
envelop
e
protein
locat
didii
junction
evidenc
sitedirect
mutagenesi
cryptic
epitop
inaccess
antibodi
bind
nativ
viru
particl
may
becom
expos
e
properli
fold
find
suggest
gener
antiprm
antibodi
enhanc
denv
infect
may
complet
avoid
even
immun
strategi
employ
e
protein
alon
subunit
e
protein
dengu
viru
denv
flaviviru
four
relat
antigen
distinct
serotyp
infect
approxim
million
peopl
year
peopl
exhibit
lifethreaten
form
sever
dengu
dengu
haemorrhag
fever
dhf
dengu
shock
syndrom
dss
current
lack
treatment
licens
vaccin
mean
dengu
pose
seriou
public
health
threat
infect
one
serotyp
denv
confer
lifelong
immun
homolog
serotyp
limit
crossprotect
remain
three
serotyp
presenc
crossreact
nonneutr
antibodi
gener
primari
infect
suggest
enhanc
pathogen
subsequ
infect
via
process
antibodydepend
enhanc
ade
success
safe
vaccin
candid
must
therefor
elicit
protect
longlast
immun
respons
four
serotyp
recent
immunolog
studi
shown
human
antidenv
immun
respons
domin
prmspecif
antibodi
primari
secondari
infect
prmspecif
antibodi
highli
crossreact
nonneutr
complex
immatur
denv
imdenv
abil
render
normal
noninfecti
imdenv
highli
infecti
caus
concern
current
vaccin
candid
contain
nativ
dengu
prm
compon
current
vaccin
strategi
whether
natur
attenu
recombinantli
attenu
yellow
feverdengueviru
chimera
chemic
inactiv
viru
dna
vaccin
recombin
subunit
protein
vaccin
vaccin
candid
contain
prm
protein
solubl
recombin
envelop
e
protein
e
domain
subunit
vaccin
may
thu
becom
increasingli
import
gain
deeper
understand
earli
denvspecif
immun
respons
human
four
serotyp
denv
sequenti
screen
nonimmun
human
fab
phage
display
librari
broadli
crossreact
prmspecif
antibodi
domin
screen
fab
highest
affin
fabigg
convert
fulllength
human
format
thorough
character
antibodi
fabigg
found
high
affin
conform
epitop
prm
like
prm
antibodi
capabl
restor
infect
virtual
noninfecti
immatur
denv
imdenv
fccrbear
cell
antibodi
also
crossreact
e
protein
fine
map
sitedirect
mutagenesi
studi
local
epitop
di
dii
junction
e
would
inaccess
nativ
viru
particl
suggest
possibl
immun
strategi
employ
e
protein
alon
subunit
e
protein
may
abl
complet
avoid
gener
antiprm
antibodi
enhanc
denv
infect
aed
albopictu
cell
atcc
maintain
leibovitz
media
gibco
invitrogen
supplement
fetal
bovin
serum
fb
c
co
cell
atcc
human
erythroleukem
cell
atcc
maintain
rpmi
glutamax
medium
rpmi
gibco
invitrogen
contain
fb
incub
c
co
vero
cell
atcc
grown
medium
gibco
invitrogen
supplement
fb
sodium
pyruv
neaa
cell
atcc
cultur
dulbecco
modifi
eagl
medium
dmem
gibco
invitrogen
supplement
fb
c
co
mous
monoclon
antibodi
specif
ediii
edii
flavivirus
prm
respect
chimer
human
construct
clone
fab
portion
variabl
light
heavi
chain
express
vector
contain
human
framework
express
cell
conjug
hrp
perform
use
lightninglink
hrp
conjug
kit
innova
bioscienc
dengu
strain
hawaii
dengu
strain
new
guinea
c
ngc
st
dengu
strain
dengu
strain
passag
vero
cell
assay
unless
otherwis
state
viru
titer
determin
plaqu
assay
bhk
cell
immatur
denv
imdenv
produc
describ
previous
briefli
media
infect
vero
cell
replac
dpi
nh
cl
medium
fb
sodium
pyruv
non
essenti
amino
acid
ps
mm
lglutathion
mm
nh
cl
cultur
supernat
harvest
day
imdenv
purifi
peg
precipit
viru
titer
determin
genom
contain
particl
gcp
ml
quantifi
realtim
pcr
qpcr
describ
previous
ascertain
bind
specif
fabigg
direct
bind
elisa
dengu
viru
perform
use
standard
elisa
method
briefli
pfuwel
purifi
coat
maxisorb
plate
follow
block
use
sm
follow
incub
mgml
denguespecif
antibodi
plate
probe
hrpconjug
antihuman
iggfc
secondari
antibodi
antimous
iggfc
secondari
antibodi
pierc
detect
step
subsequ
elisa
follow
method
unless
otherwis
state
determin
bind
affin
fabigg
direct
bind
elisa
perform
serial
dilut
fabigg
result
fit
onesit
bind
hyperbola
use
prism
graphpad
san
diego
usa
peptid
phage
elisa
mg
nonrel
control
antibodi
coat
maxisorb
plate
incub
phage
follow
detect
hrpconjug
secondari
antibodi
denvinfect
vero
cell
cell
fix
permeablil
aceton
c
min
presenc
viru
detect
fabigg
mgml
follow
stain
fitcconjug
antihuman
igg
zymax
invitrogen
cell
mount
mowiol
sigma
imag
captur
use
fluoresc
microscop
olympu
denvinfect
vero
cell
harvest
day
postinfect
lyse
cold
lysi
buffer
triton
mm
phenylmethylsulfonyl
fluorid
pmsf
mgml
pepstatin
mm
kcl
pb
min
ice
equal
volum
load
dye
ad
cell
lysat
sdspage
transfer
onto
nitrocellulos
membran
block
membran
probe
denguespecif
antibodi
rt
hr
detect
hrpconjug
antihuman
iggfc
antimous
iggfc
secondari
antibodi
develop
chemiluminesc
supersign
west
pico
chemiluminesc
substrat
pierc
establish
bind
target
fabigg
competit
elisa
epitopecharacter
monoclon
antibodi
carri
plate
prepar
direct
bind
elisa
block
serial
dilut
ad
plate
incub
hr
rt
follow
addit
fabigg
mgml
incub
hr
rt
bound
antigenantibodi
complex
detect
hrpconjug
antihuman
iggfc
secondari
antibodi
pierc
develop
describ
competit
western
fabigg
incub
hr
rt
appli
block
membran
min
rt
hrpconjug
antihuman
iggfc
secondari
antibodi
appli
detect
bound
min
rt
wash
pbst
radioact
immunoprecipit
cell
harvest
hr
later
prepar
describ
previous
immunoprecipit
sd
disrupt
protein
complex
lysat
infect
cell
incub
sd
min
c
sd
concentr
dilut
immunoprecipit
precipit
protein
analys
silver
stain
sdspage
silver
stain
plu
kit
biorad
western
blot
random
dodecapeptid
librari
new
england
biolab
pan
identifi
antibodi
epitop
per
instruct
manual
first
round
pan
carri
mgml
fabigg
immobil
maxisorb
immunotub
nunc
amplifi
phage
enrich
three
round
pan
solut
use
protein
g
sepharos
altern
round
pan
one
round
neg
select
protein
g
sepharos
carri
minim
nonspecif
binder
isol
peptid
phage
sequenc
map
protein
structur
use
peptiop
server
crystal
structur
prme
heterodim
neutral
ph
protein
data
bank
pdb
access
code
graphic
visual
carri
use
msi
weblab
viewlit
accelri
test
whether
isol
peptid
phage
inhibit
bind
natur
epitop
inhibit
elisa
carri
serial
dilut
peptid
phage
start
pfuml
pfu
incub
fabigg
hr
appli
plate
min
rt
bound
antibodi
detect
hrpconjug
antihuman
iggfc
secondari
antibodi
hr
rt
test
inhibit
capac
peptid
phage
western
blot
preincub
mgml
fabigg
pfu
peptid
phage
pfu
sm
hr
carri
appli
membran
transblot
lysat
min
hrpconjug
antihuman
iggfc
secondari
antibodi
appli
detect
bound
fabigg
min
rt
membran
process
describ
previous
visual
reactiv
band
gene
portion
contain
prme
describ
puttikhunt
et
al
amplifi
ngc
cdna
use
primer
clone
pcmvmycer
vector
via
restrict
site
nco
xho
creat
plasmid
construct
pcmvprme
use
templat
select
amino
acid
residu
predict
epitop
mutat
sitedirect
mutagenesi
use
quikchang
multi
sitedirect
mutagenesi
kit
stratagen
agil
technolog
pcr
reaction
subsequ
clone
step
carri
accord
manufactur
instruct
substitut
amino
acid
mutant
construct
confirm
sequenc
mutant
express
cell
harvest
hr
posttransfect
immunoblot
analysi
immunoprecipit
experi
determin
abil
fabigg
neutral
dengu
infect
vitro
prnt
carri
bhk
cell
describ
previous
ade
assay
perform
describ
previous
briefli
preform
immun
complex
prepar
incub
serial
dilut
antibodi
multipl
gcp
per
cell
mog
rpmi
mm
c
hr
appli
cell
ubottom
plate
nunc
supernat
harvest
hr
postinfect
viru
titer
quantifi
plaqu
assay
follow
isol
human
nonimmun
fabphag
librari
pan
serotyp
denv
sequenti
fig
fabigg
convert
full
length
human
materi
method
ensur
antibodi
specif
denv
viral
protein
elisa
ifa
perform
serotyp
denv
grown
vero
cell
line
fabigg
react
infect
cell
without
crossreact
noninfect
cell
control
indic
determin
fab
bind
inde
viral
host
fig
b
c
use
direct
elisa
fabigg
found
high
affin
serotyp
denv
fig
hypermut
suggest
antibodi
like
gener
earli
immun
respons
denv
broadli
character
epitop
fabigg
denv
use
competit
elisa
well
character
denv
antibodi
includ
mousederiv
specif
ediii
crossreact
antibodi
recogn
edii
flavivirus
crossdenv
reactiv
antiprm
antibodi
make
use
human
versu
parent
murin
antibodi
hrpconjug
versu
nonconjug
refer
antibodi
shown
selfcompet
fig
signific
competit
observ
fabigg
nondenv
specif
control
antibodi
howev
bind
fabigg
decreas
significantli
presenc
dosedepend
manner
indic
fabigg
recogn
epitop
prm
similar
fig
confirm
target
protein
fabigg
western
blot
analysi
carri
denvinfect
vero
cell
lysat
recombin
ectodomain
e
protein
reduc
nonreduc
condit
nonreduc
condit
control
antibodi
recogn
respect
target
protein
cell
lysat
detect
kda
e
protein
serotyp
kda
protein
detect
kda
prm
serotyp
fig
remark
fabigg
detect
e
prm
serotyp
howev
bind
abolish
presenc
reduc
agent
indic
epitop
conform
control
antibodi
except
lost
bind
target
protein
reduc
condit
fig
expect
sinc
recogn
linear
epitop
ediii
wherea
conform
sensit
agreement
competit
elisa
data
compet
fabigg
epitop
western
blot
format
wherea
incub
abolish
bind
prm
e
protein
fig
given
abil
fabigg
bind
prm
e
western
blot
immunoprecipit
carri
bhk
cell
lysat
elucid
fabigg
bind
protein
solut
initi
radioact
immunoprecipit
show
fabigg
bind
e
kda
prm
kda
protein
precipit
wherea
precipit
e
protein
fig
howev
prm
intrins
interact
e
form
heterodim
possibl
antibodi
bind
one
compon
heterodim
would
pull
address
dissoci
heterodim
sd
perform
prior
assay
immunoprecipit
protein
resolv
reduc
sdspage
visual
silver
stain
ident
precipit
protein
verifi
nonreduc
western
blot
analysi
respect
fig
control
antibodi
abl
precipit
correspond
bind
partner
despit
abil
recogn
prm
e
western
blot
fabigg
precipit
prm
taken
collect
data
indic
bind
prm
e
epitop
e
access
nativ
protein
dttsensit
previous
map
epitop
use
linear
peptid
attempt
similar
approach
locat
bind
epitop
fabigg
inhibit
elisa
carri
use
synthet
mer
linear
peptid
cover
prm
well
librari
short
overlap
linear
peptid
mimotop
correspond
prm
e
materi
method
howev
none
linear
peptid
abl
significantli
inhibit
bind
fabigg
fig
suggest
epitop
discontinu
next
fabigg
screen
use
random
dodecapeptid
phage
librari
approach
previous
use
map
antibodybind
motif
peptidephag
clone
randomli
select
second
third
fourth
round
pan
bind
specif
confirm
direct
bind
elisa
fabigg
reactiv
clone
sequenc
check
list
common
targetunrel
peptid
tup
elimin
peptid
react
constant
region
antibodi
protein
ag
sepharos
plastic
surfac
tup
detect
result
uniqu
clone
fall
three
main
consensu
group
contain
motif
w
tlsv
k
lx
pxw
contain
motif
aktmp
contain
motif
kxpxw
tabl
map
peptid
sequenc
use
peptiop
server
crystal
structur
prme
heterodim
neutral
ph
pdb
identifi
three
main
cluster
predict
epitop
locat
sinc
pepitop
assum
input
peptid
mimic
surfac
residu
buri
residu
elimin
search
figur
local
fabigg
predict
epitop
crystal
structur
prme
heterodim
pdb
bind
specif
peptidephag
cluster
conform
epitop
predict
pepitop
server
display
prme
heterodim
crystal
structur
neutral
ph
solventaccess
surfac
highlight
prm
pink
edi
red
edii
yellow
ediii
blue
fp
cyan
b
bind
specif
peptidephag
fabigg
test
direct
elisa
format
mgml
fabigg
nondenv
specif
human
antibodi
hu
immobil
maxisorb
plate
abil
peptidephag
inhibit
fabigg
bind
investig
c
elisa
western
blot
analysi
elisa
peptidephag
pfuml
incub
fabigg
hr
rt
applic
immobil
min
rt
bound
fabigg
detect
hrpconjug
antihuman
iggfc
percentag
inhibit
fabigg
bind
peptidephag
shown
averag
three
experi
error
bar
repres
standard
error
mean
pvalu
western
blot
analysi
mgml
fabigg
incub
pfu
purifi
sm
pfu
peptidephag
clone
hr
rt
appli
membran
transblot
viral
lysat
min
rt
peptid
kxpxw
motif
could
mostli
map
highest
score
cluster
locat
prmedii
interfac
except
map
cluster
probabl
due
poorer
sequenc
match
lower
align
score
remain
two
motif
map
second
highest
score
cluster
span
edi
edii
fig
verifi
specif
identifi
motif
nine
repres
clone
select
tabl
assess
abil
bind
fabigg
direct
elisa
crossreact
peptidephag
clone
control
antibodi
observ
confirm
bind
fabigg
specif
fig
peptidephag
clone
test
abil
inhibit
fabigg
bind
immobil
although
select
peptidephag
clone
weakli
inhibit
fabigg
bind
clone
cluster
cluster
significantli
compet
respect
fig
signific
inhibit
bind
prm
e
also
observ
western
blot
howev
notic
inhibit
observ
fig
align
peptid
sequenc
respect
cluster
reveal
aa
match
respect
fig
may
explain
differ
abil
two
peptid
phage
clone
inhibit
bind
fabigg
confirm
residu
assign
predict
epitop
prm
e
cluster
residu
mutant
made
prme
construct
puttikhunt
cowork
previous
shown
fold
correctli
express
prme
epitop
two
mutant
gener
fig
reactiv
fabigg
test
western
blot
analysi
use
control
antibodi
antibodi
react
respect
protein
target
nonmut
prme
protein
howev
bind
fabigg
prm
protein
almost
complet
abolish
mutat
prm
residu
fig
mutat
e
residu
within
sequenc
hand
signific
impact
reactiv
fabigg
fig
detect
verifi
express
mutant
verifi
e
epitop
eight
mutant
gener
fig
control
antibodi
abl
detect
respect
protein
target
mutant
apart
figur
local
peptid
sequenc
crystal
structur
prme
heterodim
pdb
purpl
green
peptid
sequenc
align
predict
cluster
cluster
navi
blue
cluster
black
prme
crystal
structur
path
peptid
phage
sequenc
highlight
particip
residu
cluster
peptid
phage
label
match
residu
purpl
green
number
accordingli
mismatch
residu
grey
respect
protein
domain
highlight
appear
nonviabl
fig
bind
e
also
appear
affect
mutat
introduc
fig
like
caus
chang
local
conform
rather
drop
express
level
sinc
prmbind
normal
notabl
bind
fabigg
e
protein
mutant
sever
affect
particular
fabigg
fail
detect
e
wherea
bind
prm
mutant
affect
fig
togeth
result
confirm
epitop
identifi
peptidephag
display
previou
studi
antiprm
antibodi
shown
antibodi
gener
nonneutr
capabl
render
noninfecti
immatur
denv
imdenv
particl
infecti
fccrmediat
process
inde
fabigg
fail
neutral
serotyp
denv
highest
concentr
test
mgml
prnt
assay
tabl
next
abil
fabigg
enhanc
infect
determin
carri
ade
assay
fccrbear
cell
specif
infect
virus
establish
qpcr
plaqu
assay
significantli
higher
standardgrown
fig
enhanc
infect
observ
antibodi
except
nondenv
specif
antibodi
denvspecif
antibodi
caus
approxim
increas
infect
compar
igg
control
fig
fabigg
nonneutr
capabl
enhanc
infect
prmcontain
viru
prepar
entir
rang
concentr
test
infect
virtual
noninfecti
imdenv
also
significantli
enhanc
fabigg
level
similar
caus
fold
increas
infect
rel
control
igg
fig
enhanc
imdenv
infect
similar
observ
sinc
epitop
affect
matur
state
henc
enhanc
equal
well
fail
enhanc
infect
cell
possibl
due
occlus
epitop
pr
peptid
indic
immunoprecipit
protein
profil
fig
gain
deeper
understand
earli
immun
respons
denv
isol
characteris
highli
crossreact
antibodi
fragment
nonimmun
human
fabphag
librari
show
near
germlin
sequenc
upon
convers
fulllength
igg
show
crossreact
four
serotyp
denv
could
compet
prmspecif
mous
antibodi
intriguingli
fabigg
found
recogn
e
prm
western
blot
analysi
conform
depend
manner
crossreact
e
prm
observ
antibodi
isol
mice
well
human
patient
howev
bind
epitop
antibodi
remain
unknown
observ
usual
explain
gener
crossreact
antiprm
antibodi
initi
immunoprecipit
experi
fabigg
precipit
prm
e
protein
howev
upon
dissoci
prm
interact
e
addit
sd
prm
precipit
fabigg
pinpoint
prm
nativ
bind
target
similarli
precipit
e
upon
addit
sd
wherea
protein
profil
precipit
affect
possibl
due
epitop
fusion
loop
e
occlud
presenc
prm
free
e
protein
pull
presenc
absenc
sd
epitop
map
use
randompeptid
phage
display
librari
approach
wide
use
identif
linear
conform
epitop
two
peptid
phage
clone
cluster
cluster
display
signific
inhibit
fabigg
bind
immobil
elisa
also
abl
significantli
block
bind
fabigg
nonreduc
western
blot
analysi
may
due
better
sequenc
match
predict
cluster
compar
fig
henc
higher
affin
peptid
fabigg
ascertain
authent
predict
epitop
predict
residu
confirm
sitedirect
mutagenesi
peptid
sequenc
residu
within
epitop
found
principl
residu
involv
interact
prm
fabigg
also
critic
bind
corrobor
result
competit
assay
bind
e
protein
realli
affect
mutat
aa
residu
within
epitop
contrast
signific
impact
caus
mutat
residu
within
epitop
combin
mutat
complet
abolish
bind
fabigg
e
protein
establish
critic
residu
within
epiotp
taken
togeth
result
suggest
fabigg
recognis
two
epitop
denv
solventaccess
epitop
prm
principl
bind
epitop
cryptic
epitop
e
mimic
prm
epitop
avail
nativ
functionallyfold
e
protein
epitop
highli
conserv
across
four
denv
serotyp
well
two
flavivirus
japanes
enceph
viru
west
nile
viru
increas
diverg
yellow
fever
viru
tickborn
enceph
viru
fig
current
dengu
vaccin
consist
prm
e
protein
studi
perform
tickborn
enceph
viru
indic
proper
fold
e
requir
chaperon
function
prm
howev
demonstr
studi
recent
report
prmspecif
antibodi
abl
restor
enhanc
infect
imdenv
partial
matur
denv
may
worthwhil
consid
altern
vaccin
approach
minim
antiprm
respons
vaccin
design
find
studi
also
suggest
partial
denatur
unfold
e
protein
vaccin
prepar
may
result
exposur
cryptic
epitop
potenti
induc
antibodi
threaten
ade
capabl
recent
studi
investig
acut
earli
convalesc
b
cell
respons
dengu
patient
found
dengu
viru
signific
b
cell
activ
capac
caus
transient
high
appear
plasmablast
plasma
cell
coincid
denguespecif
igg
antibodi
day
onset
fever
similar
fabigg
germlin
sequenc
suggest
antibodi
present
immun
repertoir
individu
given
inher
high
affin
antibodi
may
preferenti
select
clonal
expans
maintain
memori
inde
antibodi
crossreact
prm
e
isol
memori
b
cell
primari
secondari
dengu
patient
origin
immunogen
crossreact
antibodi
difficult
determin
sinc
gener
cours
natur
infect
would
interest
identifi
epitop
germlin
antibodi
compar
sequenc
fabigg
prm
mgml
synthet
peptid
correspond
prm
e
b
incub
fabigg
peptid
correspond
e
test
individu
present
group
experi
pfuml
includ
control
antigen
mer
peptid
correspond
prm
mer
custommad
peptid
cover
part
prm
mer
peptid
correspond
e
tif
